Priority Date: 12.09.13 (US 201361877101P)

ATRASENTAN MANDELATE SALTS FOR THE TREATEMENT OF KIDNEY DISEASES

  • Application ID: EP14780663
  • Status: PATENT GRANTED

Applicant

Technology company logo small
Technology Company

Attorney

no operation time available
3 offices
active in Legal Services

Specialization

This EP application has the IPC combination A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE) and C07 (ORGANIC CHEMISTRY). We found, that TransMIT GmbH, Kailuweit & Uhlemann, Lederer Keller Patentanwälte Partnerschaft mbB, Vossius & Partner Patentanwälte Rechtsanwälte mbB, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB and 231 others are specialized in this combination either. For a similar patent, they might be a good choice.

Timeline

  • 12.09.2013 - Priority Date (US 201361877101P)
  • 19.03.2015 - Publication A1 (WO2015038571)
  • 20.07.2016 - Publication A1 (EP3044222)
  • 05.07.2017 - Publication B1 (EP3044222)

IPC Classification